These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 14723376)

  • 1. Atovaquone/proguanil resistance in Africa: a case report.
    David KP; Alifrangis M; Salanti A; Vestergaard LS; Rønn A; Bygbjerg IB
    Scand J Infect Dis; 2003; 35(11-12):897-8. PubMed ID: 14723376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa.
    Schwartz E; Bujanover S; Kain KC
    Clin Infect Dis; 2003 Aug; 37(3):450-1. PubMed ID: 12884171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune north American traveller to west Africa.
    Kuhn S; Gill MJ; Kain KC
    Am J Trop Med Hyg; 2005 Apr; 72(4):407-9. PubMed ID: 15827276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers.
    Musset L; Pradines B; Parzy D; Durand R; Bigot P; Le Bras J
    J Antimicrob Chemother; 2006 Jan; 57(1):110-5. PubMed ID: 16319183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe.
    Wichmann O; Muehlberger N; Jelinek T; Alifrangis M; Peyerl-Hoffmann G; Muhlen M; Grobusch MP; Gascon J; Matteelli A; Laferl H; Bisoffi Z; Ehrhardt S; Cuadros J; Hatz C; Gjorup I; McWhinney P; Beran J; da Cunha S; Schulze M; Kollaritsch H; Kern P; Fry G; Richter J;
    J Infect Dis; 2004 Nov; 190(9):1541-6. PubMed ID: 15478057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [What is the value of the combination atovaquone-proguanil for the clinician?].
    Delmont J
    Med Trop (Mars); 2002; 62(3):232-6. PubMed ID: 12244917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lengthy antimalarial activity of atovaquone in human plasma following atovaquone-proguanil administration.
    Edstein MD; Kotecka BM; Anderson KL; Pombo DJ; Kyle DE; Rieckmann KH; Good MF
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4421-2. PubMed ID: 16189139
    [No Abstract]   [Full Text] [Related]  

  • 8. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
    Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro recrudescence of Plasmodium falciparum parasites suppressed to dormant state by atovaquone alone and in combination with proguanil.
    Thapar MM; Gil JP; Björkman A
    Trans R Soc Trop Med Hyg; 2005 Jan; 99(1):62-70. PubMed ID: 15550263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atovaquone/proguanil for the prophylaxis and treatment of malaria.
    Patel SN; Kain KC
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):849-61. PubMed ID: 16307498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of action of antimalarials. Value of combined atovaquone/proguanil].
    Touze JE; Fourcade L; Pradines B; Hovette P; Paule P; Heno P
    Med Trop (Mars); 2002; 62(3):219-24. PubMed ID: 12244914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of atovaquone-proguanil for treatment of acute multidrug-resistant Plasmodium falciparum malaria in Thailand.
    Krudsood S; Patel SN; Tangpukdee N; Thanachartwet W; Leowattana W; Pornpininworakij K; Boggild AK; Looareesuwan S; Kain KC
    Am J Trop Med Hyg; 2007 Apr; 76(4):655-8. PubMed ID: 17426165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyses of cytochrome b mutations in Plasmodium falciparum isolates in Thai-Myanmar border.
    Naoshima-Ishibashi Y; Iwagami M; Kawazu S; Looareesuwan S; Kano S
    Travel Med Infect Dis; 2007 Mar; 5(2):132-4. PubMed ID: 17298921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.
    Lacy MD; Maguire JD; Barcus MJ; Ling J; Bangs MJ; Gramzinski R; Basri H; Sismadi P; Miller GB; Chulay JD; Fryauff DJ; Hoffman SL; Baird JK
    Clin Infect Dis; 2002 Nov; 35(9):e92-5. PubMed ID: 12384852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical studies using the combination atovaquone-proguanil as malaria prophylaxis in non-immune adult and child travelers].
    Camus D; Dutoit E; Masson V; Inglebert P; Delhaes L
    Med Trop (Mars); 2002; 62(3):225-8. PubMed ID: 12244915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experience with the combination atovaquone-proguanil in the treatment of uncomplicated Plasmodium falciparum malaria--report of 112 cases].
    Malvy D; Djossou F; Vatan R; Pistone T; Etienne G; Longy-Boursier M; Le Bras M
    Med Trop (Mars); 2002; 62(3):229-31. PubMed ID: 12244916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short report: no evidence of cardiotoxicity of atovaquone-proguanil alone or in combination with artesunate.
    Gupta RK; Van Vugt M; Paiphun L; Slight T; Looareesuwan S; White NJ; Nosten F
    Am J Trop Med Hyg; 2005 Aug; 73(2):267-8. PubMed ID: 16103586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Atovaquone/proguanil. Prophylaxis and treatment of malaria].
    Lundgren JD; Dragsted UB
    Ugeskr Laeger; 2000 Jul; 162(31):4177-81. PubMed ID: 10962933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa.
    Happi CT; Gbotosho GO; Folarin OA; Milner D; Sarr O; Sowunmi A; Kyle DE; Milhous WK; Wirth DF; Oduola AM
    Malar J; 2006 Oct; 5():82. PubMed ID: 17020611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology of malaria in Cameroon. XVII. Baseline monitoring of atovaquone-resistant Plasmodium falciparum by in vitro drug assays and cytochrome b gene sequence analysis.
    Basco LK
    Am J Trop Med Hyg; 2003 Aug; 69(2):179-83. PubMed ID: 14506774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.